Quarterly Earnings

A sharp revenue drop and net loss for IZEA masks a major strategic pivot. With $46M in cash, the company is betting its future on enterprise clients.

A pivotal ATF ruling reclassifies the BolaWrap as a restraint tool, not a weapon. This opens a vast private market, but as the tool expands beyond police, new questions of oversight arise.

While the dry bulk market is strong, Pangaea's Q2 earnings reveal a model where specialized fleets and integrated logistics deliver superior, market-beating margins.

Summit Midstream posts strong Q2 earnings, but a closer look reveals a strategic pivot, funding a Williston revival while grappling with declining assets.

As VolitionRx readies its Q2 update, investors and scientists look for proof that its pioneering epigenetic tests can translate into commercial success.

National Health Investors' Q2 results reveal a bold strategy: selling a $560M legacy portfolio to fuel an aggressive expansion into private-pay senior housing.

Pason Systems' Q2 results reveal a company thriving not just on market tailwinds, but on strategic tech investments and operational leverage in a complex energy sector.

The South American giant posted record EBITDA, but the real story lies in its masterful navigation of volatile urea and ethanol markets.

The building materials giant overcame a brutal Q1, but a closer look reveals a complex strategy of restructuring, asset sales, and operational pivots.

As Semtech prepares its Q2 earnings call, all eyes are on its performance in AI data centers and IoT. Will the results validate the market's bullish outlook?

With a strong cash position and key clinical trials advancing for ALS and FTD, Coya is executing a disciplined strategy to tackle neurodegenerative diseases.

Shedding legacy costs, TONX reports a 400% surge in staking revenue, riding the wave of TON's network upgrades and its deep integration with Telegram.

With a 23% revenue jump and losses halved, 908 Devices is proving its handheld chemical detectors are more than just gadgets—they're a strategic necessity.

After a history of losses, Syra Health posts a second profitable quarter. We analyze the tech-driven strategy and key contracts fueling its turnaround.

Janus International hits a 500,000-unit milestone for its Nokē smart lock system, but Q2 results reveal a steep profit drop and a lowered earnings forecast.

With a 200% earnings surge fueled by rare metals, Neo Performance Materials' strategic European expansion challenges global supply chain dominance.

The Ontario lumber producer posts a striking Q2 profit after a deep loss, but the surprise resignation of its CEO raises questions about future stability.

Gencor Industries posted a stellar quarter with an 85% jump in operating income, fueled by a record backlog. But is this just a cyclical peak?

Security National Financial boosts profits despite falling revenue, revealing a masterclass in operational efficiency and a long-term strategy that defies convention.

Draganfly posts 26% revenue growth and secures major defense contracts, but a widening comprehensive loss reveals the high cost of its aggressive expansion strategy.